KT109
Product Specifications
CAS Number
1402612-55-8
Target
Others, MAGL
Related Pathways
Metabolism, Others
Bioactivity
KT109 is a selective inhibitor of DAGLβ (IC50 = 42 nM) . KT109-treated wild-type mice displayed reductions in LPS-induced allodyni as well as in DAGL-β (-/-) micea. Repeated KT109 administration prevented the expression of LPS-induced allodynia, without evidence of tolerance. Intraplantar injection of KT109 into the LPS-treated paw, but not the contralateral paw, reversed the allodynic responses. KT109 also reversed allodynia in the CCI and CINP models and lacked discernible side effects (e.g. anxiogenic behaviour, gross motor deficits or gastric ulcers) .
Smiles
O=C(N1CCCCC1Cc1ccccc1)n1cc(nn1)-c1ccc(cc1)-c1ccccc1
Molecular Formula
C27H26N4O
Molecular Weight
422.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
031940-HRP 200 µL
AP1S3, NT (AP1S3, AP-1 complex subunit sigma-3, Adapter-related protein complex 1 sigma-1C subunit, Adaptor protein complex AP-1 sigma-1C subunit, Clathrin assembly protein complex 1 sigma-1C small chain, Golgi adaptor HA1/AP1 adaptin sigma-1C subunit, Sigma 1C subunit of AP-1 clathrin, Sigma-adaptin 1C, Sigma1C-adaptin) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 
LS009819-20ug 20 µg
TSC22D2 (NM_014779) Human Over-expression Lysate
Sign In for Pricing
View Details 
orb1716616-01 50 µL
GSDMD (Full Length+N terminal) polyclonal antibody
Sign In for Pricing
View Details orb1716616-02 100 µL
GSDMD (Full Length+N terminal) polyclonal antibody
Sign In for Pricing
View Details